
Adrienne Rivlin, Partner, L.E.K. Consulting
Advertisement

Dr. Adrienne Rivlin is a partner in L.E.K.’s Healthcare practice, based in the London office. She advises private and public sector organisations across the pharmaceutical, biotech, medical device and consumer healthcare sectors on their critical commercial challenges, including corporate and portfolio strategy development; product launch; pricing and market access; clinical governance structures and processes; and commercial and regulatory due diligence.
Email: a.rivlin@lek.com
Articles by Adrienne Rivlin, Partner, L.E.K. Consulting

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novo Reports Real-World Data Showing Weight Loss After Switch to Oral Semaglutide Pill
2
Roundup: Hengrui Pharma and Novo Enter Exclusive License Agreement for HRS-1596, AstraZeneca Enters Collaboartion with Summit Therapeutics
3
New U.S. Guidance Lays Out Exemptions for 100% Tariffs: Report
4
As Peptide Rulemaking Stalls, FDA Enforcement Moves Forward
5